NJ Supreme Court Upholds $4.5M Vioxx Verdict

Law360, New York (September 29, 2009, 2:59 PM EDT) -- New Jersey's highest court on Tuesday upheld an award of $4.5 million in compensatory damages in a failure-to-warn suit brought by a diabetic man who suffered a heart attack after using Merck & Co. Inc.'s anti-inflammatory prescription drug Vioxx.

Weitz & Luxenberg PC announced Tuesday that the Supreme Court of New Jersey had just released its May 7 ruling in McDarby v. Merck, which upholds lower courts' decision to grant John McDarby and his widow, Irma McDarby, compensatory damages in a case involving Vioxx and its...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.